San Diego’s Small Cap Stocks Arrive in Force at Roth Capital’s Largest Investor Conference
Bruce V. Bigelow3/15/10Follow @bvbigelow
(Page 2 of 2)
biotechnology sector; the other addresses leading companies and pioneering treatments in the race to develop new anti-viral drug therapies.
—A track nearly as large features 90 companies based in China (but with stock that trades on U.S. markets). This morning’s China panel includes a discussion of case studies and lessons learned, conducting effective due diligence, assessment of company accounting capabilities, legal considerations, and other topics.
—Roth also has organized a cleantech investing panel on the changing landscape in power production and distribution that includes a discussion of electric grid modernization and the influence of federal stimulus funds, demand-side management, and the role natural gas is expected to play in future power generation.
All told, 21 San Diego companies also are scheduled to make presentations:
Alphatec Holdings (NASDAQ: ATEC)
Genoptix (NASDAQ: GXDX)
Overland Storage (NASDAQ: OVRL)
Qualcomm (NASDAQ: QCOM)
Cytori Therapeutics (NASDAQ: CYTX)
DexCom (NASDAQ: DXCM)
NuVasive (NASDAQ: NUVA)
Volcano (NASDAQ: VOLC)
Cypress Bioscience (NASDAQ: CYPB)
NexMed (NASDAQ: NEXM)
Santarus (NASDAQ: SNTS)
DivX (NASDAQ: DIVX)
Maxwell Technologies (NASDAQ: MXWL)
Anadys Pharmaceutical (NASDAQ: ANDS)
Ardea Biosciences (NASDAQ: RDEA)
Inovio Biomedical (NASDAQ: INO)
Neurocrine Biosciences (NASDAQ: NBIX)
Vical Inc. (NASDAQ: VICL)
Sequenom (NASDAQ: SQNM)
Halozyme Therapeutics (NASDAQ: HALO)
Lifevantage (NASDAQ: LFVN)
Senomyx (NASDAQ: SNMX)
